We have verified that MG53 catalyzed the K48-linked poly-ubiquitination and degradation of RAC1 at Lys5, and we further tried to define whether MG53 exerted its anti-tumor effect via its ubiquitous modification at Lys5 residue of RAC1. The gene discussed is TRIM72; the disease is neoplasm.